Clearbridge Health (FRA:5C6) EV-to-EBIT : -0.32 (As of Jun. 24, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Clearbridge Health EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Clearbridge Health's Enterprise Value is €7.30 Mil. Clearbridge Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-23.14 Mil. Therefore, Clearbridge Health's EV-to-EBIT for today is -0.32.

The historical rank and industry rank for Clearbridge Health's EV-to-EBIT or its related term are showing as below:

FRA:5C6' s EV-to-EBIT Range Over the Past 10 Years
Min: -14.84 Med: -3.42 Max: 24.16
Current: -0.32

During the past 10 years, the highest EV-to-EBIT of Clearbridge Health was 24.16. The lowest was -14.84. And the median was -3.42.

FRA:5C6's EV-to-EBIT is ranked worse than
100% of 101 companies
in the Medical Diagnostics & Research industry
Industry Median: 20.28 vs FRA:5C6: -0.32

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Clearbridge Health's Enterprise Value for the quarter that ended in Dec. 2023 was €10.80 Mil. Clearbridge Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-23.14 Mil. Clearbridge Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -214.31%.

Clearbridge Health EV-to-EBIT Historical Data

The historical data trend for Clearbridge Health's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearbridge Health EV-to-EBIT Chart

Clearbridge Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

-9.26

21.44

-5.80

-2.72

-0.48

Clearbridge Health Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial													-5.80	-	-2.72	-	-0.48

Competitive Comparison of Clearbridge Health's EV-to-EBIT

For the Diagnostics & Research subindustry, Clearbridge Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clearbridge Health's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Clearbridge Health's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Clearbridge Health's EV-to-EBIT falls into.

Clearbridge Health EV-to-EBIT Calculation

Clearbridge Health's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	7.303	/	-23.135
	=	-0.32

Clearbridge Health's current Enterprise Value is €7.30 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Clearbridge Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-23.14 Mil.

Clearbridge Health (FRA:5C6) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Clearbridge Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-23.135	/	10.795046
	=	-214.31 %

Clearbridge Health's Enterprise Value for the quarter that ended in Dec. 2023 was €10.80 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Clearbridge Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was €-23.14 Mil.

Clearbridge Health EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Clearbridge Health's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Clearbridge Health (FRA:5C6) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Clearbridge Health Ltd (FRA:5C6) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

1H3:Singapore

Address

37 Jalan Pemimpin, No. 08-05 Mapex, Singapore, SGP, 577177

Website

https://www.clearbridgehealth.com

Clearbridge Health Ltd provides health care services. It is an integrated healthcare group with end-to-end diagnostic abilities, deploying non-invasive tests to identify and manage illness. The segments of the company are Strategic investments; Healthcare systems; Medical clinics; Corporate segment and Investment. It derives key revenue from the Healthcare systems and Medical clinics. The Healthcare systems segment involves, provision of diagnostic services and manufacturing of and research and development on diagnostic related products, and provision of renal care services by partnering with medical device equipment manufacturers and hospitals. The Medical clinics segment involves, provision of general medical and clinical services. The group has a business presence in all over the world.

Clearbridge Health (FRA:5C6) Headlines

No Headlines